The University of Cincinnati joins a Phase 1 clinical trial testing CAR-T cell therapy for MS, exploring this cancer ...

Researchers have created over 400 distinct types of human nerve cells in vitro, vastly expanding the diversity available for ...

A simple blood test has been shown to be 98% accurate at distinguishing between patients with ALS and those without the disease, with potential implications for treatment if it's approved for ...

TORONTO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intellig ...

Precision Neuroscience is testing its brain-computer interface in human patients at the Mount Sinai Health System in New York City. As CNBC watched from an operating room in April, the company set ...

Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G sTREM2 Assay for Research Use Only. H.U. Group Holdings Inc. and its wholly-owned subsidiary ...

--Firefly Neuroscience, Inc., an Artificial Intelligence technology company developing innovative neuroscientific solutions that improve brain health outcomes for patients with mental illnesses ...